Hongfei Mi

Xiamen University — China

Medicine · Health Sciences

5h-index114citations10works3.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(3), COVID-19 Clinical Research Studies(2), SARS-CoV-2 and COVID-19 Research(2), Antibiotic Resistance in Bacteria(2), Pancreatitis Pathology and Treatment(2)

Publications10 total

Global burden of metabolic dysfunction-associated steatotic liver disease from 1990 to 2021 and the prediction for the next 10 years
Preventive Medicine Reports·2025· 6 citedOpen Access
Epidemiology of device-associated healthcare-associated infections and carbapenem-resistant <i>Enterobacteriaceae</i> in intensive care units: a 7-year multicenter surveillance in Shanghai, China
Infection Control and Hospital Epidemiology·2025· 1 cited
Fatty liver index as an independent predictor of all-cause and disease-specific mortality
European Journal of Gastroenterology & Hepatology·2024· 4 citedOpen Access
Trends and multi-model prediction of hepatitis B incidence in Xiamen
Infectious Disease Modelling·2024· 2 citedOpen Access
Short-term effectiveness of single-dose intranasal spray COVID-19 vaccine against symptomatic SARS-CoV-2 Omicron infection in healthcare workers: a prospective cohort study
EClinicalMedicine·2023· 11 citedOpen Access
Association between the overall burden of comorbidity and Ct values among the older patients with Omicron infection: Mediated by inflammation
Frontiers in Immunology·2023· 5 citedOpen Access
Effectiveness of Inactivated Vaccine against SARS-CoV-2 Delta Variant Infection in Xiamen, China—A Test-Negative Case-Control Study
Vaccines·2023· 2 citedOpen Access
Colonization of Toxigenic Clostridium difficile Among Intensive Care Unit Patients: A Multi-Centre Cross-Sectional Study
Frontiers in Cellular and Infection Microbiology·2020· 11 citedOpen Access
The mechanism of ROS regulation of antibiotic resistance and antimicrobial lethality.
PubMed·2016· 12 cited
Dimethyl Sulfoxide Protects Escherichia coli from Rapid Antimicrobial-Mediated Killing
Antimicrobial Agents and Chemotherapy·2016· 60 citedOpen Access

Frequent Co-authors

Tingjuan He(6), Shuhao Ren(4), Meixia Wang(4), Bijie Hu(3), Ruixin Zhang(3), Chenghao Su(3), Chenghao Su(3), Dai Wang(2), Yunxin Xue(2), Xilin Zhao(2), Yan Shen(2), Xiang Chen(2), Jiabing Lin(2), Wei Jiang(2), Zhi Zhang(1), Jianjun Niu(1), Yuzhi Hong(1), Karl Drlica(1), Li-na Ma(1), Rong Bao(1)